How does this affect treatment?

How does this affect treatment?

Cleveland Clinic

2 months
10 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Sudha Amarnath, MD of Cleveland Clinic discusses how this will affect treatment and clinicians today.

_____

Preoperative pelvic radiation (XRT), with or without concurrent chemotherapy, is safe and effective in patients with inflammatory bowel disease (IBD) and locally advanced rectal cancer, according to Cleveland Clinic research presented at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting.

IBD is a risk factor for the development of rectal cancers, and IBD patients are frequently diagnosed with locally advanced cancers.

“Patients who have IBD are at a higher risk of developing rectal cancer compared to the general population, and also tend to have worse prognoses with locally-advanced cancers,” says Cleveland Clinic radiation oncologist Sudha Amarnath, MD, the study’s lead author.

Read the rest here: https://consultqd.clevelandclinic.org/preoperative-pelvic-radiation-is-safe-effective-in-patients-with-ibd-and-rectal-cancer/

Up Next Autoplay
Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
Category: Colorectal Cancer
3 Views
WUSTL 1 month
Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
Category: Colorectal Cancer
24 Views
WUSTL 1 month
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
11 Views
Cancer-News 2 months
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
71 Views
Cancer-News 2 months
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Category: Colorectal Cancer
33 Views
Cancer-News 2 months
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
4 Views
Cleveland Clinic 2 months
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
12 Views
Cleveland Clinic 2 months
IDEA: Factors to consider
IDEA: Factors to consider
Category: Colorectal Cancer
4 Views
moasc 3 months
The impact the IDEA data will have on clinicians
The impact the IDEA data will have on clinicians
Category: Colorectal Cancer
3 Views
moasc 3 months